← FDA Drug Approvals (Drugs@FDA)

METHOCARBAMOL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: POINTVIEW HLDINGS · Approved 2021-04-30

Drug application

FDA Application #

ANDA212623

Application type

Abbreviated New Drug Application (Generic)

Brand name

METHOCARBAMOL

Generic name

METHOCARBAMOL

Active ingredients

METHOCARBAMOL

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

POINTVIEW HLDINGS

Manufacturer

Marlex Pharmaceuticals, Inc.

First approval

2021-04-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown